GitLife Biotech

Startup

Build, Protect, and Share Bio-Innovations on a Single Collaborative Platform

GitLife Biotech is a UK-based pioneering synthetic biology company, leading the way in Biological rights and IP Management—the process of tracking, securing, and verifying the provenance, ownership, and usage of engineered biological materials.

We understand the critical challenges facing the synthetic biology industry, such as IP protection, biosecurity risks, and regulatory uncertainty, which can hinder innovation and collaboration. GitLife addresses these issues with a secure, collaborative platform that helps scientists, R&D leaders, and business executives manage biological assets with confidence. Scientists gain precise version control and seamless project handovers, R&D leaders get real-time oversight and secure collaboration, and business leaders strengthen IP protection, ensure regulatory compliance, and streamline commercialization.

At the heart of GitLife’s ecosystem, CellRepo® provides version-controlled digital records, ensuring full traceability from R&D to commercialisation. Complementing this, GenoSignature™ embeds unique molecular markers within engineered cells, protecting provenance and ownership

By tackling synthetic biology’s biggest challenges, GitLife empowers biotech companies, CROs, and manufacturers to safeguard discoveries, accelerate breakthroughs, and bring innovations to market with confidence.

Incorporate CellRepo® into the day-to-day operations of your lab, enabling you to trace every modification, build with precision, share securely, and protect your innovations—making it an integral part of your lab's workflow.

Visit us at stand number S9 for a live demo and see how GitLife can help transform your approach to managing biological assets.

website